{
  "id": "adv_mhgap#screening_cues_a20df638",
  "content": "»\nantipsychotic medication. Go to PSY 2, Management\nperson with dementia and avoid hostility towards,\nC onsider medications only in settings where specific for details about antipsychotic medication.\nor neglect of, the person.\ndiagnosis of Alzheimer’s Disease can be made AND where\nF ollow the principles of:\nEncourage the carers to seek help if they are experiencing adequate support and supervision by specialists and\ndifficulty or strain in caring for their loved one. monitoring (for side-effects and response) from carers is – “Start low, go slow” (titrate) and review the need regularly\navailable. (at least monthly).\nProvide information to the carer regarding dementia,\n– Use the lowest effective dose.\nkeeping in mind the wishes of the person with dementia. If appropriate:\n– Monitor the person for extrapyramidal symptoms (EPS)\nProvide training and support in specific skills, e.g. F or dementia with suspected Alzhemer’s Disease,\nAvoid i.v. haloperidol\nmanaging difficult behaviour, if necessary. To be most and with CLOSE MONITORING, consider cholinesterase\neffective, elicit active participation, e.g. role play. inhibitors (e.g. donepezil, galantamine, rivastigmine) Avoid diazepam.\nOR memantine.\nConsider providing practical support when feasible,\ne.g. home-based respite care. Another family or suitable F or dementia with associated vascular disease, consider",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "screening_cues",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Screening Cues »\nantipsychotic medication. Go to PSY 2, Management\nperson with dementia and avoid hostility towards,\nC onsider medications only in settings where specific for details about antipsychotic medication.\nor neglect of, the person.\ndiagnosis of Alzheimer’s Disease can be made AND where\nF ollow the principles of:\nEncourage the carers to seek help if they are experiencing adequate support and supervision by specialists and\ndifficulty or strain in caring for their loved one. monitoring (for side-effects and response) from carers is – “Start low, go slow” (titrate) and review the need regularly\navailable. (at least monthly).\nProvide information to the carer regarding dementia,\n– Use the lowest effective dose.\nkeeping in mind the wishes of the person with dementia. If appropriate:\n– Monitor the person for extrapyramidal symptoms (EPS)\nProvide training and support in specific skills, e.g. F or dementia with suspected Alzhemer’s Disease,\nAvoid i.v. haloperidol\nmanaging difficult behaviour, if necessary. To be most and with CLOSE MONITORING, consider cholinesterase\neffective, elicit active participation, e.g. role play. inhibitors (e.g. donepezil, galantamine, rivastigmine) Avoid diazepam.\nOR memantine.\nConsider providing practical support when feasible,\ne.g. home-based respite care. Another family or suitable F or dementia with associated vascular disease, consider »\nantipsychotic medication. go to psy 2, management\nperson with dementia and avoid hostility towards,\nc onsider medications only in settings where specific for details about antipsychotic medication."
}